Peripheral Vascular Stents Market Size & Growth Forecast 2026–2035, By Segments (Mode of Delivery, Type, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Peripheral Vascular Stents Market size was worth USD 2.03 Billion in 2025 and is poised to grow at a 7.5% CAGR between 2026 and 2035, exceeding USD 4.18 Billion by 2035. The industry revenue for 2026 is assessed at USD 2.17 billion.
Get more details on this report
Request Free Sample ReportPeripheral Vascular Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 46.42% share, driven by high diagnosis rates, established minimally invasive treatment pathways, and strong interventional vascular infrastructure across care centers.
- Asia Pacific is growing at 8.48% CAGR due to expanding vascular care access, increasing procedural volumes, and broader adoption of endovascular interventions in developing healthcare systems.
Segment Momentum
- Balloon-expandable Stents captured 56.62% of the market in 2025, supported by their reliable deployment accuracy and predictable vessel scaffolding in routine peripheral vascular procedures.
- Bioabsorbable Stents are the fastest-growing type segment because demand is increasing for temporary vessel support that reduces long-term implanted material while supporting the healing process.
Market Expansion Drivers
- Rising prevalence of peripheral arterial diseases increasing demand for vascular interventions.
- Expanding aging population driving higher incidence of vascular occlusions and PAD cases.
- Advancements in minimally invasive stent technologies improving procedural success and recovery outcomes.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key companies in the peripheral vascular stents market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Cook Medical LLC (United States), Cordis Corporation (United States), MicroPort Scientific Corporation (China), iVascular S.L.U. (Spain), Lifetech Scientific Corporation (China), Becton, Dickinson and Company (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As the diagnosed burden of peripheral arterial disease rises, treatment pathways are shifting from symptom management alone toward earlier endovascular intervention, directly increasing demand for the peripheral vascular stents market. Patients presenting with claudication, limb ischemia, and recurring arterial narrowing increasingly require vessel patency restoration when medication and lifestyle measures prove insufficient, which pushes hospitals and vascular specialists to expand interventional capacity. This trend strengthens market development because stents are often selected to maintain blood flow after lesion crossing and angioplasty, especially in patients with complex or recurrent arterial obstruction.
Expanding aging population driving higher incidence of vascular occlusions and PAD cases
An aging patient base is steadily increasing the number of people living with calcified, narrowed, and fragile peripheral arteries, creating a larger addressable population for the peripheral vascular stents market. Older adults are more likely to present with comorbidities such as diabetes, hypertension, and atherosclerosis that complicate circulation in the lower limbs and raise the likelihood of repeat vascular assessment and intervention. That clinical profile supports market expansion by increasing procedure volumes in outpatient vascular centers and hospitals, where stents are used to manage occlusive disease while avoiding the burden of more invasive surgical alternatives in high-risk elderly patients.
Advancements in minimally invasive stent technologies improving procedural success and recovery outcomes
Technology improvements in delivery systems, flexibility, radial strength, and lesion-specific stent design are influencing market adoption by making endovascular treatment more dependable in anatomically challenging peripheral vessels. In the peripheral vascular stents market, better trackability and conformability allow physicians to treat longer, more tortuous, or calcified lesions with greater precision, which improves confidence in stent placement and reduces reluctance to intervene in difficult cases. Recovery advantages associated with minimally invasive procedures also shape referral behavior, as providers and patients increasingly favor options that shorten hospital stays and support faster return to mobility.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of peripheral arterial diseases increasing demand for vascular interventions | 2.00% | High | North America, Europe, Asia Pacific | High | Near Term |
| Expanding aging population driving higher incidence of vascular occlusions and PAD cases | 1.70% | High | North America, Europe, Asia Pacific | High | Mid Term |
| Advancements in minimally invasive stent technologies improving procedural success and recovery outcomes | 1.50% | High | North America, Europe | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 46.42% share of the peripheral vascular stents market in 2025, supported by high procedure volumes, broad access to vascular diagnosis and intervention, and established use of minimally invasive treatment pathways across hospitals and specialty centers. The region’s leadership is reinforced by a mature clinical environment in which patients with peripheral artery disease are identified earlier and more consistently, allowing stent-based treatment to be integrated into routine care. Strong specialist availability and well-developed interventional infrastructure also help sustain steady product utilization in practice.
Asia Pacific is projected to expand at an 8.48% CAGR over the forecast period, with growth in the peripheral vascular stents market being propelled by improving access to vascular care and a rising volume of patients entering treatment pathways. Adoption is accelerating as healthcare systems across the region expand interventional capabilities and more providers incorporate endovascular procedures into everyday practice. Growth is also being supported by broader treatment availability in developing healthcare markets, where increasing procedural capacity is translating into greater use of stent-based peripheral interventions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Endovascular Procedure ExcellenceGermany maintains strong adoption of endovascular therapies supported by experienced vascular specialists. The peripheral vascular stents market prioritizes durable products designed for procedural precision and reliable clinical performance across diverse treatment settings.
France 🇫🇷
Structured Clinical AdoptionFrance integrates peripheral vascular stents through established treatment protocols emphasizing clinical effectiveness and patient safety. Manufacturers serving France benefit from demonstrating robust evidence, product reliability, and compatibility with routine vascular intervention practices.
Italy 🇮🇹
Expanding Peripheral InterventionItaly is increasing the use of endovascular procedures across hospitals managing peripheral vascular diseases. The peripheral vascular stents market supports demand for dependable technologies that simplify intervention while addressing a growing need for minimally invasive treatment options.
Japan 🇯🇵
Minimally Invasive PreferenceJapan continues expanding minimally invasive vascular interventions to address the needs of an aging patient population. The peripheral vascular stents market favors compact, high-performance devices that enhance treatment precision while supporting efficient post-procedure recovery.
South Korea 🇰🇷
Technology-Driven Vascular CareSouth Korea encourages adoption of advanced vascular intervention technologies through modern healthcare infrastructure. The peripheral vascular stents market benefits from demand for innovative devices that improve treatment flexibility and support high-quality clinical outcomes.
United States 🇺🇸
Complex Vascular SolutionsThe U.S. peripheral vascular stents market is driven by increasing use of minimally invasive procedures for peripheral artery disease. Healthcare providers seek versatile stent technologies that address complex vascular conditions while supporting efficient intervention and long-term patient care.
Segment Leadership and Growth Trends
Peripheral Vascular Stents Market Share (%), Mode of Delivery, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportBalloon-expandable Stents held a 56.62% share of the peripheral vascular stents market in 2025, reflecting their established role in procedures where precise placement and controlled deployment are essential. Their leadership is maintained through the practical need for high positional accuracy in peripheral interventions, particularly in lesion settings where physicians prioritize predictable expansion and immediate vessel scaffolding. This procedural reliability keeps Balloon-expandable Stents firmly anchored in routine use across the peripheral vascular stents market.
Self-expanding Stents are emerging as the fastest-growing mode of delivery segment in the peripheral vascular stents market because they are increasingly aligned with the clinical demands of more dynamic and anatomically challenging peripheral vessels. Their growth is backed by the need for stents that can adapt to vessel movement, compression, and varying diameters after placement, which makes them well suited to cases where flexibility matters more than fixed expansion precision. That practical advantage is helping Self-expanding Stents gain momentum relative to alternative delivery modes.
Type Segment Analysis: Drug Eluting Stents (DES) (Largest Segment) vs Bioabsorbable Stents (Fastest-Growing Segment)
In 2025, Drug Eluting Stents (DES) accounted for a 58.7% share of the peripheral vascular stents market, maintaining leadership through their established use in reducing restenosis risk after intervention. Their position is backed by the practical value of combining mechanical vessel support with localized drug delivery, which addresses a core treatment challenge in peripheral artery procedures. This dual therapeutic role helps Drug Eluting Stents remain the preferred choice in the peripheral vascular stents market where durable patency outcomes are a central concern.
Bioabsorbable Stents represent the fastest-growing type segment in the peripheral vascular stents market as treatment preferences increasingly shift toward solutions that provide temporary support without leaving a permanent implant behind. Their momentum comes from the practical appeal of reducing long-term foreign material in the vessel while still supporting the artery during the critical healing phase. Compared with conventional permanent stent options, this evolving treatment approach is driving stronger interest in Bioabsorbable Stents.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Mode of Delivery | Self-expanding Stents, Balloon-expandable Stents | Balloon-expandable Stents | Self-expanding Stents |
| Type | Drug Eluting Stents (DES), Bare Metal Stents (BMS), Bioabsorbable Stents | Drug Eluting Stents (DES) | Bioabsorbable Stents |
| End-use | Hospitals & Cardiac Centers, Ambulatory Surgical Centers, Others | Hospitals & Cardiac Centers | Ambulatory Surgical Centers |
| Product | Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, Others | Iliac Artery Stents | Carotid Artery Stents |
Competitive Landscape and Market Positioning
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. Terumo Corporation (Japan)
4. BIOTRONIK SE & Co. KG (Germany)
5. Cook Medical LLC (United States)
6. Cordis Corporation (United States)
7. MicroPort Scientific Corporation (China)
8. iVascular S.L.U. (Spain)
9. Lifetech Scientific Corporation (China)
10. Becton Dickinson and Company (United States)
Continuous improvement in vascular intervention techniques is shaping the peripheral vascular stents market, with innovation centered on flexibility and procedural efficiency. Enhanced material science is enabling better adaptability to complex anatomies. The peripheral vascular stents market is advancing toward more precise and patient-specific solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cordis | Oct-23 | Cordis completed the acquisition of MedAlliance in a landmark transaction valued at up to USD 1.135 billion. By integrating MedAlliance’s proprietary SELUTION SLR sustained-release sirolimus drug-eluting balloon technology, Cordis has significantly bolstered its peripheral vascular portfolio, positioning the company to address the treatment of complex peripheral artery disease with a differentiated, stentless therapeutic platform. |
| Medtronic | 2025 | Medtronic introduced advanced self-expanding nitinol stent systems designed with enhanced flexibility and vessel patency performance. These next-generation stents target the challenges of peripheral artery disease, providing clinicians with improved deliverability and long-term structural integrity in tortuous anatomy, which enhances the company's competitive position in the peripheral interventional market. |
| Biotronik | 2025 | Biotronik launched next-generation bioabsorbable vascular scaffold technologies for minimally invasive cardiovascular and peripheral therapies. By advancing its bioresorbable platform, the company is targeting the shift toward temporary support structures that dissolve after vessel healing, offering a strategic alternative to permanent metallic implants and addressing a key segment of the vascular intervention market. |
| Boston Scientific | 2024 | Boston Scientific expanded its peripheral drug-eluting stent portfolio, specifically optimizing designs for femoropopliteal artery treatment. This product enhancement focuses on improving clinical outcomes in high-complexity vascular cases, reflecting the company’s strategic commitment to maintaining its market leadership through continuous innovation in specialized peripheral vascular devices. |
| Terumo Medical | 2024 | Terumo Medical launched a new series of low-profile catheter delivery systems specifically engineered for complex peripheral artery disease procedures. This development focuses on enhancing physician control and procedural access in challenging vascular environments, reinforcing Terumo’s competitive strategy in peripheral vascular intervention by improving the ease and precision of stent delivery. |
| Abbott | 2023 | Abbott expanded its vascular imaging integration technologies to support precision-guided peripheral interventions. By integrating advanced imaging capabilities with its stent and catheter systems, the company provides physicians with real-time, high-fidelity visualization, enabling more accurate stent placement and better long-term outcomes in peripheral vascular procedures. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Peripheral Vascular Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Peripheral Vascular Stents Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow big is the peripheral vascular stents market?
What is the expected industry size of peripheral vascular stents by 2035?
What is driving earlier adoption of peripheral vascular stents in treatment pathways?
How are technological improvements shaping procedural success in peripheral stenting?
Why do Balloon-expandable Stents hold the largest share of the peripheral vascular stents market?
Which type segment is expanding the fastest in the peripheral vascular stents market?
Why is North America the leading region in the peripheral vascular stents market?
What factors are driving growth in the Asia Pacific peripheral vascular stents market?
Who are the major participants shaping the peripheral vascular stents landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization